Accuracy Coverage Pricing Contact
UCB

UCB (UCB)

UCB is a Belgian manufacturer of biopharmaceutical products. The company is engaged in the provision of therapy for central nervous system disorders, inflammatory and oncology disorders. UCB head office is located in Brussels.

They have consistently paid a level or increasing dividend for over 5 years, although this is projected to dip slightly before resuming its upward trajectory.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 90.0¢
2007 92.0¢ 2.2%
2008 92.0¢ 0%
2009 96.0¢ 4.3%
2010 98.0¢ 2.1%
2011 100.0¢ 2.0%
2012 102.0¢ 2.0%
2013 104.0¢ 2.0%
2014 106.0¢ 1.9%
2015 110.0¢ 3.8%
2016 115.0¢ 4.5%
2017 118.0¢ 2.6%
2018 125.0¢ 5.9%
2019 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
26 Apr 2010 29 Apr 2010 2009 Final Semiannually Paid 96¢
02 May 2011 05 May 2011 2010 Final Annually Paid 98¢
27 Apr 2012 03 May 2012 2011 Final Annually Paid 100¢
02 May 2013 07 May 2013 2012 Final Annually Paid 102¢
29 Apr 2014 05 May 2014 2013 Final Annually Paid 104¢
04 May 2015 06 May 2015 2014 Final Annually Paid 106¢
29 Apr 2016 03 May 2016 2015 Final Annually Paid 110¢
28 Apr 2017 03 May 2017 2016 Final Annually Paid 115¢
27 Apr 2018 02 May 2018 2017 Final Annually Paid 118¢
Login Login 2018 Final Annually Forecast Login
Login Login 2019 Final Annually Forecast Login

UCB optimized dividend - 12 month history

Optimized dividend graph demo

UCB share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial